Channelrhodopsins: Visual regeneration and neural activation by a light switch

New Biotechnology

Volumn 30, Issue 5, 2013, Pages 461-474

  G, Natasha ^a,b   Tan, Aaron ^a,b   Farhatnia, Yasmin ^a   Rajadas, Jayakumar ^c   Hamblin, Michael R ^d,e,f   Khaw, Peng T ^g,h   Seifalian, Alexander M ^a,i  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^g MOORFIELDS EYE HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC MANIPULATIONS; HEART MUSCLE CONTRACTIONS; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIALS; RETINAL DEGENERATIONS; RETINAL GANGLION CELLS; SEVEN-TRANSMEMBRANE PROTEINS; SPINAL CORD INJURIES (SCI);

ALGAE; DEPOLARIZATION; MAMMALS; OPHTHALMOLOGY; PROTEINS; TISSUE;

IONS;

11 CIS RETINAL; CHANNELRHODOPSIN; CHR2 YFP PROTEIN; COMPLEMENTARY DNA; CRE RECOMBINASE; CYCLIC GMP PHOSPHODIESTERASE; ELONGATION FACTOR 1ALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; METABOTROPIC RECEPTOR 6; RETINAL; RHODOPSIN; UNCLASSIFIED DRUG;

CHLAMYDOMONAS REINHARDTII; CLONING; CONFORMATIONAL TRANSITION; DEPOLARIZATION; DROSOPHILA MELANOGASTER; GENE EXPRESSION; GENE REPLACEMENT THERAPY; GENE TARGETING; GENETIC TRANSFECTION; ILLUMINATION; NEUROTRANSMISSION; NONHUMAN; OPTIC NERVE; OPTOGENETICS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; RETINA DEGENERATION; RETINA GANGLION CELL; RETINA MACULA DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TRANSGENIC ANIMAL; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; HUMANS; LIGHT; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; REGENERATION; RETINAL DEGENERATION; RETINAL GANGLION CELLS; RHODOPSIN; SPINAL CORD INJURIES; SYNAPTIC TRANSMISSION; VISION, OCULAR;

EID: 84880162868     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2013.04.007     Document Type: Review

References (91)

1. Deisseroth K. Optogenetics. Nature Methods 2011, 8:26-29.
2. Dugue G.P., Akemann W., Knopfel T. A comprehensive concept of optogenetics. Progress in Brain Research 2012, 196:1-28.
3. LaLumiere R.T. A new technique for controlling the brain: optogenetics and its potential for use in research and the clinic. Brain Stimulation 2011, 4:1-6.
4. Britt J.P., McDevitt R.A., Bonci A. Use of channelrhodopsin for activation of CNS neurons. Current Protocols in Neuroscience 2012, Chapter 2, Unit2.16.
5. Feilden T. Switching on a light in the brain 2012, http://www.bbc.co.uk/news/science-environment-20513292.
6. Wykes R.C., Heeroma J.H., Mantoan L., Zheng K., Macdonald D.C., Deisseroth K., et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Science Translational Medicine 2012, 4:161ra152.
7. Arenkiel B.R. In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron 2007, 54:205-218.
8. Ji Z.G., Ishizuka T., Yawo H. Channelrhodopsins-their potential in gene therapy for neurological disorders. Neuroscience Research 2012, 75(1):6-12.
9. Bi A. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 2006, 50:23-33.
10. Muller M., Bamann C., Bamberg E., Kuhlbrandt W. Projection structure of channelrhodopsin-2 at 6Å resolution by electron crystallography. Journal of Molecular Biology 2011, 414:86-95.
11. Abilez O.J. Multiscale computational models for optogenetic control of cardiac function. Biophysical Journal 2011, 101:1326-1334.
12. Tomita H. Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. Experimental Eye Research 2010, 90:429-436.
13. Hegemann P., Moglich A. Channelrhodopsin engineering and exploration of new optogenetic tools. Nature Methods 2011, 8:39-42.
14. Holmes D. Is neurology ready to see the light?. Lancet Neurology 2012, 11:663-664.
15. Tomita H., Sugano E., Isago H., Tamai M. Channelrhodopsins provide a breakthrough insight into strategies for curing blindness. Journal of Genetics 2009, 88:409-415.
16. Nagel G. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:13940-13945.
17. Ullrich S., Nagel G., Nagel G. Degradation of channelopsin-2 in the absence of retinal and degradation resistance in certain mutants. Biological Chemistry 2012, 394(2):271-280.
18. Oesterhelt D. The structure and mechanism of the family of retinal proteins from halophilic archaea. Current Opinion in Structural Biology 1998, 8:489-500.
19. Lin J.Y. Optogenetic excitation of neurons with channelrhodopsins: light instrumentation, expression systems, and channelrhodopsin variants. Progress in Brain Research 2012, 196:29-47.
20. Buchen L. Neuroscience: illuminating the brain. Nature 2010, 465:26-28.
21. Nagel G. Channelrhodopsin-1: a light-gated proton channel in green algae. Science 2002, 296:2395-2398.
22. Sineshchekov O.A., Jung K.H., Spudich J.L. Two rhodopsins mediate phototaxis to low- and high-intensity light in Chlamydomonas reinhardtii. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8689-8694.
23. Suzuki T. Archaeal-type rhodopsins in Chlamydomonas: model structure and intracellular localization. Biochemical and Biophysical Research Communications 2003, 301:711-717.
24. Lin J.Y. A user's guide to channelrhodopsin variants: features, limitations and future developments. Experimental Physiology 2011, 96:19-25.
25. Fenno L., Yizhar O., Deisseroth K. The development and application of optogenetics. Annual Review of Neuroscience 2011, 34:389-412.
26. Reichel M.B. An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse. British Journal of Ophthalmology 2001, 85:341-344.
27. Ali R.R. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Human Molecular Genetics 1996, 5:591-594.
28. Sakamoto T. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy?. Ophthalmology 1995, 102:1417-1424.
29. Miyoshi H., Takahashi M., Gage F.H., Verma I.M. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:10319-10323.
30. Lotery A.J. Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors. Human Gene Therapy 2002, 13:689-696.
31. Feng G. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
32. Feng G., Lu J., Gross J. Generation of transgenic mice. Methods in Molecular Medicine 2004, 99:255-267.
33. Nagel G. Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. Current Biology 2005, 15:2279-2284.
34. Schoonheim P.J., Arrenberg A.B., Del Bene F., Baier H. Optogenetic localization and genetic perturbation of saccade-generating neurons in zebrafish. Journal of Neuroscience 2010, 30:7111-7120.
35. Schroll C. Light-induced activation of distinct modulatory neurons triggers appetitive or aversive learning in Drosophila larvae. Current Biology 2006, 16:1741-1747.
36. Han X. Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain. Neuron 2009, 62:191-198.
37. Weick J.P. Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 2010, 28:2008-2016.
38. Flusberg B.A. Fiber-optic fluorescence imaging. Nature Methods 2005, 2:941-950.
39. Flusberg B.A., Jung J.C., Cocker E.D., Anderson E.P., Schnitzer M.J. In vivo brain imaging using a portable 3.9 gram two-photon fluorescence microendoscope. Optics Letters 2005, 30:2272-2274.
40. Doroudchi M.M. Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. Molecular Therapy 2011, 19:1220-1229.
41. Lagali P.S. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nature Neuroscience 2008, 11:667-675.
42. Tomita H. Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer. Investigative Ophthalmology and Visual Science 2007, 48:3821-3826.
43. Farah N., Reutsky I., Shoham S. Patterned optical activation of retinal ganglion cells. Conference Proceedings of IEEE Engineering in Medicine and Biology Society 2007, 6368-6370.
44. Thyagarajan S. Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells. Journal of Neuroscience 2010, 30:8745-8758.
45. Greenberg K.P., Pham A., Werblin F.S. Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism. Neuron 2011, 69:713-720.
46. Isago H. Age-dependent differences in recovered visual responses in Royal College of Surgeons rats transduced with the channelrhodopsin-2 gene. Journal of Molecular Neuroscience 2012, 46:393-400.
47. Tomita H. Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter. PLoS One 2009, 4:e7679.
48. Ivanova E., Pan Z.H. Evaluation of the adeno-associated virus mediated long-term expression of channelrhodopsin-2 in the mouse retina. Molecular Vision 2009, 15:1680-1689.
49. Ivanova E., Roberts R., Bissig D., Pan Z.H., Berkowitz B.A. Retinal channelrhodopsin-2-mediated activity in vivo evaluated with manganese-enhanced magnetic resonance imaging. Molecular Vision 2010, 16:1059-1067.
50. Ivanova E., Hwang G.S., Pan Z.H., Troilo D. Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina. Investigative Ophthalmology and Visual Science 2010, 51:5288-5296.
51. Sugano E. Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy. Gene Therapy 2010, 18:266-274.
52. Zhang F., Wang L.P., Boyden E.S., Deisseroth K. Channelrhodopsin-2 and optical control of excitable cells. Nature Methods 2006, 3:785-792.
53. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience 2005, 8:1263-1268.
54. Gunaydin L.A. Ultrafast optogenetic control. Nature Neuroscience 2010, 13:387-392.
55. Berndt A., Yizhar O., Gunaydin L.A., Hegemann P., Deisseroth K. Bi-stable neural state switches. Nature Neuroscience 2009, 12:229-234.
56. Adesnik H., Scanziani M. Lateral competition for cortical space by layer-specific horizontal circuits. Nature 2010, 464:1155-1160.
57. Zhang F., Aravanis A.M., Adamantidis A., de Lecea L., Deisseroth K. Circuit-breakers: optical technologies for probing neural signals and systems. Nature Reviews Neuroscience 2007, 8:577-581.
58. Wentz C.T. A wirelessly powered and controlled device for optical neural control of freely-behaving animals. Journal of Neural Engineering 2011, 8:046021.
59. Chader G.J. Animal models in research on retinal degenerations: past progress and future hope. Vision Research 2002, 42:393-399.
60. Michael-Titus A., Revest P., Shortland P. The nervous system: basic science and clinical conditions 2010, Churchill Livingstone.
61. Lopez R. Transplanted retinal pigment epithelium modifies the retinal degeneration in the RCS rat. Investigative Ophthalmology and Visual Science 1989, 30:586-588.
62. Sheedlo H.J., Gaur V., Li L.X., Seaton A.D., Turner J.E. Transplantation to the diseased and damaged retina. Trends in Neurosciences 1991, 14:347-350.
63. Lavail M.M., Li L., Turner J.E., Yasumura D. Retinal pigment epithelial cell transplantation in RCS rats: normal metabolism in rescued photoreceptors. Experimental Eye Research 1992, 55:555-562.
64. Lund R.D. Retinal degeneration and transplantation in the Royal College of Surgeons rat. Eye (London) 1998, 12(Pt. 3b):597-604.
65. Aramant R.B., Seiler M.J. Retinal transplantation - advantages of intact fetal sheets. Progress in Retinal and Eye Research 2002, 21:57-73.
66. Abe T. Characterization of iris pigment epithelial cell for auto cell transplantation. Cell Transplantation 1999, 8:501-510.
67. Kaplan H.J., Tezel T.H., Berger A.S., Del Priore L.V. Retinal transplantation. Chemical Immunology 1999, 73:207-219.
68. Schraermeyer U. Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats. Cell Transplantation 2001, 10:673-680.
69. Lund R.D., Ono S.J., Keegan D.J., Lawrence J.M. Retinal transplantation: progress and problems in clinical application. Journal of Leukocyte Biology 2003, 74:151-160.
70. Yang P., Seiler M.J., Aramant R.B., Whittemore S.R. Differential lineage restriction of rat retinal progenitor cells in vitro and in vivo. Journal of Neuroscience Research 2002, 69:466-476.
71. Haruta M. In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Investigative Ophthalmology and Visual Science 2004, 45:1020-1025.
72. Dahlmann-Noor A., Vijay S., Jayaram H., Limb A., Khaw P.T. Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve. Canadian Journal of Ophthalmology 2010, 45:333-341.
73. Flannery J.G., Greenberg K.P. Looking within for vision. Neuron 2006, 50:1-3.
74. Margalit E. Retinal prosthesis for the blind. Survey of Ophthalmology 2002, 47:335-356.
75. Roska B., Werblin F. Vertical interactions across ten parallel, stacked representations in the mammalian retina. Nature 2001, 410:583-587.
76. Roska B., Molnar A., Werblin F.S. Parallel processing in retinal ganglion cells: how integration of space-time patterns of excitation and inhibition form the spiking output. Journal of Neurophysiology 2006, 95:3810-3822.
77. Bainbridge J.W. Effect of gene therapy on visual function in Leber's congenital amaurosis. New England Journal of Medicine 2008, 358:2231-2239.
78. Hauswirth W.W. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Human Gene Therapy 2008, 19:979-990.
79. Daiger S.P., Bowne S.J., Sullivan L.S. Perspective on genes and mutations causing retinitis pigmentosa. Archives of Ophthalmology 2007, 125:151-158.
80. Jones B.W. Retinal remodeling triggered by photoreceptor degenerations. Journal of Comparative Neurology 2003, 464:1-16.
81. MacLaren R.E., Bird A.C., Sathia P.J., Aylward G.W. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology 2005, 112:2081-2087.
82. Tropepe V. Retinal stem cells in the adult mammalian eye. Science 2000, 287:2032-2036.
83. Sahni J.N. Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy. Current Genomics 2011, 12:276-284.
84. McGee Sanftner L.H., Abel H., Hauswirth W.W., Flannery J.G. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Molecular Therapy 2001, 4:622-629.
85. Deisseroth K. Biological Psychiatry 2012, 71. http://www.biologicalpsychiatryjournal.com/webfiles/images/journals/bps/S0006322311X00367.pdf.
86. Bowes C. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature 1990, 347:677-680.
87. Pittler S.J., Baehr W. The molecular genetics of retinal photoreceptor proteins involved in cGMP metabolism. Progress in Clinical and Biological Research 1991, 362:33-66.
88. Mullen R.J., LaVail M.M. Inherited retinal dystrophy: primary defect in pigment epithelium determined with experimental rat chimeras. Science 1976, 192:799-801.
89. Lewis T.L., Mao T., Svoboda K., Arnold D.B. Myosin-dependent targeting of transmembrane proteins to neuronal dendrites. Nature Neuroscience 2009, 12:568-576.
90. D'Cruz P.M. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Human Molecular Genetics 2000, 9:645-651.
91. Yizhar O., Fenno L.E., Davidson T.J., Mogri M., Deisseroth K. Optogenetics in neural systems. Neuron 2011, 71:9-34.